Articles by James Calloway
Iovance Faces Make-or-Break Amtagvi Ramp as $101M Quarterly Hurdle Looms
Iovance Biotherapeutics (IOVA) fell 13.2% to $4.07 as investors weigh the steep climb to $101 million in quarterly Amtagvi revenue needed to hit 2026 guidance.
UiPath Stock Soars Past Analyst Targets After Q1 Beat
UiPath shares have surged 25.5% since July 31, trading above analyst targets. Q1 results beat expectations, but Q2 guidance signals a sequential revenue decline.
SMCI Stock Gains 1.7% as $68.5B Forecast Overshadows Margin Dip
SMCI shares rose 1.7% Friday as a $68.5B fiscal 2027 revenue forecast (30% above consensus) offset a 700-bps margin decline.
Nvidia's August Rally Faces Earnings Test as Robotics Buzz Fades
Nvidia's 12% August gain faces a narrow earnings beat expectation. With data center dominance and robotics buzz, investors await Q2 results.
Disney Gains 2% on Kingdom Hearts Buzz, But Gaming Revenue Still Hidden
Disney shares climbed 2% on Friday amid Kingdom Hearts excitement, but the company still doesn't break out gaming revenue, leaving investors guessing about its true value.
American Airlines Shares Tumble 7% as Profit Gap Widens
American Airlines shares dropped 7% after leadership changes failed to close a $1.13 billion profit gap with rivals. Analysts still see 31.5% upside.
UiPath Shares Outpace Analyst Targets Amid Insider Sale
UiPath (PATH) ended the week up 6.4%, trading 18% above the average analyst target, even as the chief accounting officer sold $831,250 in stock.
Applied Materials Shares Slide 5% on Flat Margins Despite Strong Guidance
Applied Materials (AMAT) dropped 5.2% despite strong Q4 revenue guidance, as unchanged gross margins raised questions about its 32x earnings valuation.
Cerebras Tumbles 5.3% as Valuation Concerns Override Strong Core Growth
Cerebras (CBRS) fell 5.3% Friday as investors weighed a $51.8B valuation against strong core revenue growth and a widened GAAP loss.
Plug Power Stock Climbs 6% as Service Contract Benefit Boosts Margins
Plug Power shares gained 6% this week as a $15.7 million service-contract benefit helped narrow its gross margin to near breakeven, though revenue growth targets remain a challenge.
Infleqtion Stock Surges 5.9% on Record Revenue, But Valuation Raises Eyebrows
Infleqtion shares rose 5.9% after Q2 revenue doubled and 2026 outlook was lifted, but the stock's 67x sales valuation and declining margins spark caution.